(Q81661553)

English

A bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: a study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 OR QS-21

scientific article published on 01 May 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837210%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

A bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: a study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 OR QS-21 (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837210%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

immunologic adjuvant

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837210%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Susan F Slovin

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837210%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Govind Ragupathi

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837210%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Celina Fernandez

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837210%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Matthew P Jefferson

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837210%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Meghan Diani

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837210%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Andrew S Wilton

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837210%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Shemeeakah Powell

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837210%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Maria Spassova

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837210%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Henrick Clausen

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837210%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Samuel Danishefsky

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837210%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Philip Livingston

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837210%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Howard I Scher

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837210%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

1 May 2005

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837210%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837210%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837210%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

24

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837210%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

3114-3122

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837210%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Carbohydrate vaccines in cancer: immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.072

7 January 2021

Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.072

7 January 2021

Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.072

7 January 2021

Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.072

7 January 2021

Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.072

7 January 2021

QS-21 structure/function studies: effect of acylation on adjuvant activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.072

7 January 2021

Fractionation, structural studies, and immunological characterization of the semi-synthetic Quillaja saponins derivative GPI-0100.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.072

7 January 2021

Adjuvants--a classification and review of their modes of action

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.072

7 January 2021

Effect of immunological adjuvant combinations on the antibody and T-cell response to vaccination with MUC1-KLH and GD3-KLH conjugates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.072

7 January 2021

Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.072

7 January 2021

Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.072

7 January 2021

Identifiers

10.1016/J.VACCINE.2005.01.072

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837210%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837210%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81661553&oldid=1757999002"